MIR34A and neoplasm: Furthermore, we identified multiple, additional hallmarks of CACs harboring Mir34a-deficient myeloid cells, such as increased expression of Mmp9 in neutrophils and elevated expression of Zeb2 in an inflammatory subtype of CAC tumor cells.